Loui T. Madakamutil

Vice President & Head of Discovery & Research at Nektar Therapeutics

Loui T. Madakamutil

Loui T. Madakamutil

Vice President & Head of Discovery & Research at Nektar Therapeutics

Biography

Loui T. Madakamutil, Ph.D., joined Nektar Therapeutics in June 2018 as Vice President and Head of Discovery and Research to lead the company’s overall discovery strategy, which includes delivering novel immuno-modulatory medicines in several therapeutic areas including oncology, immunology and auto-inflammatory diseases. Dr. Madakamutil is an immunologist with more than 20 years of expertise in small molecule and biologics drug discovery. He has advanced several large and small molecule compounds into Phase 1a clinical development.

Prior to joining Nektar, Dr. Madakamutil was Senior Scientific Director at Janssen Research & Development, where he was head of the rheumatology discovery team. In that role, he was responsible for the overarching discovery strategy in rheumatology and advancing portfolio assets from early ideas to proof-of-concept in humans in rheumatoid arthritis, systemic lupus erythematosus and other rheumatic diseases. Previously, he served in various positions of increasing responsibility in Drug Discovery and Early Development at Takeda Pharmaceutical Company, with his last position as Site Head, Immunology. In that role, he was responsible for driving Takeda’s discovery strategy in immunology with a focus on cancer immunology and inflammatory bowel disease. He also was responsible for lead optimization to candidate selection. Prior to Takeda, he was a scientist in the Experimental Therapeutics Group at Celgene, where he was responsible for pharmacology support in the inflammation therapeutic area.

Dr. Madakamutil received a B.S. in biochemistry from St. Xavier’s College in Ahmedabad, India, an M.S. in microbiology from the University of Baroda in Gujarat, India, and a Ph.D. in applied biology with a focus on immunology from the Cancer Research Institute in Mumbai, India. He was a postdoctoral fellow at the La Jolla Institute for Allergy and Immunology in San Diego.

Overview
RelSci Relationships

215

Relationships
RelSci Relationships are individuals Loui T. Madakamutil likely has professional access to. A relationship does not necessarily indicate a personal connection.

President, Chief Executive Officer, Director at Nektar Therapeutics

Relationship likelihood: Strong

Senior Vice President, Research & Chief Scientific Officer at Nektar Therapeutics

Relationship likelihood: Strong

Chairman at Biota Technology, Inc.

Relationship likelihood: Strong

Co-Founder at Pearl Therapeutics, Inc.

Relationship likelihood: Strong

Senior Vice President & Chief Financial Officer at Nektar Therapeutics

Relationship likelihood: Average

Senior Vice President & Chief Operating Officer at Nektar Therapeutics

Relationship likelihood: Average

Secretary, Senior Vice President & General Counsel at Nektar Therapeutics

Relationship likelihood: Average

Senior Vice President, Pharmaceutical Development & Chief Technical Operations Officer at Nektar Therapeutics

Relationship likelihood: Average

Senior Vice President, Finance & Chief Accounting Officer at Nektar Therapeutics

Relationship likelihood: Average

Senior Vice President, Clinical Development & Chief Medical Officer at Nektar Therapeutics

Relationship likelihood: Average

Paths to Loui T. Madakamutil
Potential Connections via
Relationship Science
You
Loui T. Madakamutil
Vice President & Head of Discovery & Research at Nektar Therapeutics
Career History
Vice President & Head of Discovery & Research
Tenure Unconfirmed

Nektar Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms, which are designed to improve the benefits of drugs for patients. Its product pipeline consists of drug candidates across a number of therapeutic areas, including oncology, pain, anti-infectives, anti-viral and immunology. Nektar's research and development activities involve small molecule drugs, peptides and other potential biologic drug candidates. Its drug candidates are designed to improve the pharmacokinetics, pharmacodynamics, half-life, bioavailability, metabolism or distribution of drugs and improve the overall benefits and use of a drug for the patient.

I-Ddu Site Head Tcal
Tenure Unconfirmed

Takeda California, Inc. is an American private company located in San Diego, CA, that manufactures pharmaceuticals.

Other Affiliations

Loui T. Madakamutil is affiliated with Nektar Therapeutics, Takeda California, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Loui T. Madakamutil. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Loui T. Madakamutil's profile does not indicate a business or promotional relationship of any kind between RelSci and Loui T. Madakamutil.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/person/loui-t-madakamutil-157421239
  • https://relationshipscience.com/person/loui-t-madakamutil-157421239